Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.

Item
http://www.wikidata.org/entity/Q33971524
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsHigh incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients.Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country.Allogeneic transplantation: peripheral blood vs. bone marrow.Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan.Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.A Child as a Donor for Hematopoietic Stem Cell Transplantation: Bioethical Justification-A Case Study on Sickle Cell Disease.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860

Allogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.

Item
http://www.wikidata.org/entity/Q33971524
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Allogeneic bone marrow transpl ...... randomized controlled trials.
@ast
Allogeneic bone marrow transpl ...... randomized controlled trials.
@en
type
label
Allogeneic bone marrow transpl ...... randomized controlled trials.
@ast
Allogeneic bone marrow transpl ...... randomized controlled trials.
@en
prefLabel
Allogeneic bone marrow transpl ...... randomized controlled trials.
@ast
Allogeneic bone marrow transpl ...... randomized controlled trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Allogeneic bone marrow transpl ...... randomized controlled trials.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698